상품명칭 |
Cevimelinehydrochloride |
영문 이름 |
Cevimelinehydrochloride;CevimelineHCl; C07772; Cevimeline hydrochloride hemihydrate; Spiro[1-azabicyclo[2.2.2]octane-3,5'-[1,3]oxathiolane], 2'-methyl-, hydrochloride, hydrate (2:1), cis-; Spiro[1-azabicyclo[2.2.2]octane-3,5'-[1,3]oxathiolane], 2'-methyl-, hydrochloride, hydrate (2:2:1), (2'R,3R)-rel-; (2R,2'R)-2'-methylspiro[4-azabicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane] hydrochloride hydrate (2:2:1); (2R,2'R)-2'-methylspiro[4-azabicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane] hydrochloride (1:1) |
분자식 |
C10H18ClNOS |
분자량 |
235.774 |
InChI |
InChI=1/C10H17NOS.ClH/c1-8-12-10(7-13-8)6-11-4-2-9(10)3-5-11;/h8-9H,2-7H2,1H3;1H/t8-,10-;/m1./s1 |
cas번호 |
153504-70-2 |
분자 구조 |
|
비등점 |
308.5°C at 760 mmHg |
인화점 |
140.4°C |
증기압 |
0.000676mmHg at 25°C |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|